0001209191-15-026058.txt : 20150313 0001209191-15-026058.hdr.sgml : 20150313 20150313162746 ACCESSION NUMBER: 0001209191-15-026058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150311 FILED AS OF DATE: 20150313 DATE AS OF CHANGE: 20150313 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043404176 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COOK JOSEPH C JR CENTRAL INDEX KEY: 0001024003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 15699688 MAIL ADDRESS: STREET 1: MOUNTAIN GROUP CAPITAL, LLC STREET 2: 1600 DIVISION STREET, SUITE 580 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-11 0 0001446847 IRONWOOD PHARMACEUTICALS INC IRWD 0001024003 COOK JOSEPH C JR C/O IRONWOOD PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Class A Common Stock 2015-03-11 4 S 0 2600 15.53 D 43975 D Class A Common Stock 2015-03-12 4 S 0 1200 15.54 D 42775 D Class B Common Stock 2015-03-12 4 S 0 2083 15.54 D 304080 D Class B Common Stock 24000 I By Farview Management Company, L.P. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $15.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $15.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation. The reporting person is a general partner of Farview Management Company, L.P., the beneficial owner of the securities. /s/ Halley E. Gilbert, Attorney-in-Fact 2015-03-13